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ÖZET
Amaç: Bu çalışma karpal tünel sendromlu (KTS) erkek 
hastalarda  endokrin  hormon  ve  lipid  düzeyleriyle  klinik 
özellikler  arasındaki  ilişkiyi  belirlemek  amacıyla  düzen-
lendi.
Gereç ve yöntem: Çalışmaya 15 erkek KTS hastası ve 
16 sağlıklı kontrol dahil edildi. Serum serbest T3, serbest 
T4, tiroid stimüle edici hormon (TSH), serbest testosteron, 
dehidroepiandrosteron sülfat, trigliserid ve total kolesterol 
düzeyleri analiz edildi. Klinik değerlendirmede semptom 
şiddeti ve el fonksiyonları Boston Karpal Tünel Anketi ile 
belirlendi.
Bulgular:  Karpal  tünel  sendromu  hastalarında  serum 
serbest T3, serbest T4, TSH, serbest testosteron, dehid-
roepiandrosteron sülfat, trigliserid ve total kolesterol de-
ğerleri kontrollerle benzer düzeylerdeydi (p> 0.05). KTS 
hastalarında klinik özellikler ile laboratuar parametreleri 
arasında da istatistiksel olarak anlamlı bir korelasyon yok-
tu (p> 0.05).
Sonuç:  Karpal  tünel  sendromu  olan  erkek  hastalarda 
serum serbest T3, serbest T4, TSH, serbest testosteron, 
dehidroepiandrosteron sülfat, trigliserid ve total kolesterol 
düzeyleri normal aralıkta görülmektedir. Kadın ve erkek 
hastalarda total kolesterol ve trigliserid gibi lipid düzeyleri 
ve endokrin faktörler ile KTS arasındaki ilişkiyi araştıracak 
yeni çalışmaların yapılması gerekmektedir.
Anahtar kelimeler: Karpal tünel sendromu, tiroid hormo-
nu, testosteron, lipid düzeyleri
ABSTRACT
Objectives: This study was performed to evaluate the re-
lationship between endocrine hormones, lipid levels and 
clinical  parameters  in  male  patients  with  carpal  tunnel 
syndrome (CTS).
Materials and methods: Fifteen male patients with CTS 
and 16 healthy controls were included in the study. Serum 
free T3, free T4, thyroid-stimulating hormone (TSH), free 
testosterone,  dehydroepiandrosterone  sulfate,  triglycer-
ide and total cholesterol levels were analyzed. Symptom 
severity and hand function were assessed using the Bos-
ton Carpal Tunnel Questionnaire in clinical examination.
Results: Serum free T3, free T4, TSH, free testosterone, 
dehydroepiandrosterone  sulfate,  triglyceride  and  total 
cholesterol levels were similar between CTS patients and 
controls (p> 0.05). Also, there was no statistically signifi-
cant correlation between laboratory parameters and clini-
cal characteristics in patients with CTS (p> 0.05).
Conclusion: The serum free T3, free T4, TSH, free tes-
tosterone,  dehydroepiandrosterone  sulfate,  triglyceride 
and total cholesterol levels seem within normal range in 
male CTS patients. Further studies are needed to inves-
tigate association endocrine factors, lipid levels such as 
triglyceride and total cholesterol with CTS in male and fe-
male patients.
Key words: Carpal tunnel syndrome, thyroid hormone, 
testosterone, lipid levels
INTRODUCTION
Carpal tunnel syndrome (CTS) is the most common 
peripheral compressive neuropathy in the develop-
ing  countries.1 The  chronic  mechanical  compres-
sion and ischemic damage occur due to entrapment 
of the median nerve at the level of the carpal tunnel. 
2 Serious diseases and conditions, such as rheuma-
toid arthritis, collagen tissue diseases, Colles frac-H. Uzkeser et al. Endocrine hormone and lipid levels in carpal tunnel syndrome 428
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ture, hemodialysis, and thyroid diseases may play a 
role developing CTS.
On the other hand, there is a complex relation-
ship between the central nervous system and the 
endocrine system. Especially, hypothalamus plays 
an  important  role  on  coordination  of  autonomic 
functions by neuronal and hormonal pathways. It 
was reported that CTS might occur in somatotrop 
adenomas.3
In  addition,  thyroid  hormones  contribute  to 
development of the central nervous system on the 
perinatal period and thyroid deficiency results with 
mental  retardation.  Also,  thyroid  hormones  are 
necessary for normal functions of brain on adults. 
Therefore, hypothyroidism of adults may cause de-
pression, dementia, polyneuropathy and CTS.4
However,  hypercholesterolemia  is  associated 
with fibrogenesis in various organs and in peripher-
al nerves.5 There is few study about association with 
CTS and lipid levels.5,6 Therefore we investigated 
relationship between lipid levels and CTS.
CTS is more frequent in women and the ratio 
women-men  varies  from  5.7  to  1.4  according  to 
different  prevalence  studies.7  Investigating  to  en-
docrine factors on CTS studies had generally con-
ducted in female patients. However, there is limited 
information about this topic in men. Therefore, this 
study was performed to evaluate the relationship be-
tween endocrine hormones and CTS clinical param-
eters in male patients.
MATERIALS AND METHODS
Fifteen  male  patients  with  CTS  that  admitted  to 
Physical  Medicine  and  Rehabilitation  outpatient 
clinic were included in the study. Patients were ex-
cluded in the presence of other known disease like 
diabetes, polyneuropathy or endocrine disease. Only 
idiopathic CTS with duration symptoms more than 
one year were included the study. Gold Standard for 
diagnosis of CTS is performing clinical examina-
tion and electrophysiological study with together. 
Patients  with  CTS  were  diagnosed  using  clinical 
and standard electrophysiological criteria.8
Electrophysiologic study is performed by the 
same person and all the tests are done in similar 
temperature conditions. Electrophysiological stud-
ies were performed by EMG device (Medelec Teca 
Premerie Plus vE05, 1995). Nerve conduction stud-
ies were made with surface stimulator and record-
ing electrodes at 25°C controlled room temperature 
and over 30°C hand skin temperatures. Stimulations 
with 0.1-0.2 ms were given as supramaximal by bi-
polar electrodes. Ring electrodes in sensory nerve 
conduction studies, surface square electrodes in mo-
tor nerve conduction studies were used.
Sensory nerve action potentials (SNAP) were 
assessed as antidromic. Sensory nerve conduction 
studies, 14 cm distance between 2nd finger and wrist 
for median nerve, 12 cm distance between 5th fin-
ger and wrist for ulnar nerve, 14 cm distance be-
tween 4th finger and wrist for ulnar-median nerves 
comparisons were performed on both hands of all 
patients. Measurements were made on thenar and 
hypothenar regions by stimulating from wrist me-
dian and ulnar nerves of both hands in motor nerve 
conduction  studies.  Distance  between  stimulation 
place and recording electrode was 6-8 cm. Senso-
rial conduction velocities (SCV), motor conduction 
velocities (MCV), SNAP, compound muscle action 
potentials (CMAP), distal sensory latencies (DSL) 
and distal motor latencies (DML) of median and ul-
nar nerves on both hands were measured. Also, with 
stimulations in equal distances from 4th finger, me-
dian and ulnar sensory peak latencies, amplitudes 
and conduction velocities were determined. Needle 
electromyography (EMG) was applied on abductor 
pollicis brevis muscle by using a monopolar needle 
electrode. Cases of severe CTS with evidence of 
denervation on EMG and thenar atrophy were not 
included  into  this  study. All  measurements  were 
made by the same neurophysiologist with the stan-
dardized method. CTS was diagnosed in occurrence 
of one or more criteria below in electrophysiologi-
cal investigations:
1) SCV for median nerve < 40 m/s 
2) Median nerve DML from the wrist to abduc-
tor pollicis brevis > 4.2 msec
3) DSL difference between the median and ul-
nar nerves > 0.5 ms.
Symptom severity and hand function were as-
sessed using the Boston Carpal Tunnel Question-
naire in clinical examination. The Boston Carpal 
Tunnel Questionnaire symptom severity scale and 
functional status scale were separately calculated 
in the study 9. Boston Questionnaire is a self-ad-
ministered questionnaire which assesses the sever-H. Uzkeser et al. Endocrine hormone and lipid levels in carpal tunnel syndrome 429
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ity of symptoms and the functional status of CTS. 
The symptom severity scale (SSS) consists of 11 
questions and the functional status scale (FSS) in-
cludes 8 questions. In both the overall results are 
calculated mean of the number of questions for each 
one. SSS assess the symptoms with respect to sever-
ity, frequency, time and type. FSS assess the effect 
of CTS on daily living. So, a higher score defines 
worse symptoms or dysfunctions. Sezgin et al in 
2006 were found valid and reliable to the Turkish 
version of Boston Carpal Tunnel Questionnaire.10
 The  control  group  was  formed  by  16  male 
healthy volunteers without any evidence of diseas-
es, matched in age with CTS patients. The height 
and weight of all subjects were recorded and body 
mass index (BMI) was calculated as weight (kg)/
height (m2).
Laboratory  examinations  were  applied  to  all 
patients and control subjects. Serum free T3, free 
T4, thyroid-stimulating hormone (TSH), free testos-
terone, dehydroepiandrosterone sulfate, triglyceride 
and total cholesterol levels were measured by fast-
ing blood at morning. Demographic data and labo-
ratory values were compared between the groups.
Statistical Analysis
Statistical analysis was performed with the Statis-
tical Package for the Social Sciences for Windows 
(version 11.0, Chicago, IL, USA). Statistical analy-
ses were undertaken using the Mann–Whitney U 
test and Pearson correlation test. A p value of less 
than 0.05 was accepted as statistically significant.
RESULTS
The demographic, clinical and laboratory character-
istics of patients and healthy controls are shown in 
Table 1. There was not a significant difference for 
demographic factors between two groups (p>0.05). 
Also, we did not find statistically significant differ-
ence for serum free T3, free T4, TSH, free testos-
terone, dehydroepiandrosterone sulfate, triglyceride 
and total cholesterol levels between patients with 
CTS and healthy controls (Table 2). No significant 
correlations were observed between laboratory pa-
rameters and clinical characteristics in patients with 
CTS (Table 3). Also, we did not found significant 
correlation between laboratory parameters and elec-
trophysiological parameters.
Table  1.  The  demographic  and  clinical  characteristics 
of carpal tunnel syndrome patients and healthy controls 
(mean ± SD)
CTS Controls  p
Age (years) 47.13 ± 10.40 40.88 ± 9.28 ns
BMI  29.15 ± 5.25 27.18 ± 3.38 ns
Disease duration (year) 3.33 ± 4.78 -
Symptom severity scale 23.67 ± 5.58 -
Functional status scale 11.6 ± 4.53 -
CTS: Carpal tunnel syndrome, BMI: Body mass index, ns: 
not significant
Table  2. The  laboratory  analysis  of  carpal  tunnel  syn-
drome patients and healthy controls (mean ± SD)
CTS Controls  p
Free T3 (pg/ml) 2.42 ± 0.21 2.44 ± 0.23 ns
Free T4 (ng/dl) 2.36 ± 3.58 1.02 ± 0.21 ns
TSH (µIU/ml) 1.22 ± 1.76 1.30 ± 1.23 ns
Free testosterone (ng/dl) 0.63 ±0.36 0.69 ± 0.31 ns
Dehydroepiandrosterone
 sulfate (µg/dl)
104.96±31.93 108.79±51.14 ns
Triglyceride (mg/dl) 136.87±57.14 152.13±66.56 ns
Total cholesterol (mg/dl) 201.6±44.76 172.81±52.99 ns
CTS: Carpal tunnel syndrome, TSH: thyroid-stimulating 
hormone, ns: not significant
Table 3. The results of Pearson correlation test between 
laboratory parameters and Boston Carpal Tunnel Ques-
tionnaire in patients with carpal tunnel syndrome 
SSS
r
FSS
r p
Free T3 (pg/ml) 0.4 0.5 ns
Free T4 (ng/dl) 0.06 -0.1 ns
TSH (µIU/ml) 0.1 -0.03 ns
Free testosterone (ng/dl) 0.01 0.3 ns
Dehydroepiandrosterone sulfate (µg/dl) -0.1 0.1 ns
Triglyceride (mg/dl) -0.4 -0.1 ns
Total cholesterol (mg/dl) -0.1 -0.1 ns
TSH: thyroid-stimulating hormone, SSS: Symptom Sever-
ity Scale, FSS: Functional Status Scale, ns: not signifi-
cantH. Uzkeser et al. Endocrine hormone and lipid levels in carpal tunnel syndrome 430
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DISCUSSION
Carpal tunnel stndrome is entrapment of the me-
dian nevre in the carpal tunnel region. It’s clinical 
symptoms are characterized by pain, numbness and 
tingling in the hands.11 The prevalence of certain 
diseases and conditions such as diabetes mellitus, 
thyroid  diseases,  rheumatoid  arthritis,  pregnancy 
and obesity are higher in CTS patients than in the 
general population.11,12
Female gender, increased BMI and increased 
wrist ratio represent important risk factors for de-
veloping CTS.13 The accumulation of fat tissue and 
synovial  thickening  in  obese  people  compressed 
the median nerve in the carpal canal.13 Some other 
pathophysiologic  mechanisms  may  cause  to  this 
process. Becker et al found that the association be-
tween female gender and CTS is greater in diabetic 
patients,  and  they  also  found  female  gender  and 
obesity were the strongest independent risk factors 
for CTS.14 Kouyoumdjian et al conclude that CTS 
cases have a significant correlation with higher BMI 
when compared to controls subjects; however, high-
er BMI does not represent a statistically significant 
increasing risk for more severe CTS.15 In contrast to 
the above-mentioned studies we did not find a dif-
ference for BMI values, serum triglyceride and to-
tal cholesterol levels between healthy controls and 
CTS patients.
Some studies reported gender-related differenc-
es between female and male patients with CTS.7,16,17 
In  women,  using  combined  oral  contraceptives, 
bilateral oophorectomy and pregnancy have been 
determined to be associated with CTS.18-20 Padua et 
al.16 showed that the mean age was higher in men but 
the duration of symptoms was shorter than women. 
In addition, male patients with CTS had more se-
vere electrophysiological damage but they reported 
fewer  symptoms  compared  with  women.  Mon-
delli et al also reported that the duration of symp-
toms was shorter in men and Boston Carpal Tunnel 
Questionnaire scores were higher in women than in 
men.7 However, we did not find a study investigat-
ing serum testosterone and dehydroepiandrosterone 
sulfate levels in female or male patients with CTS. 
In our study, serum testosterone and dehydroepi-
androsterone sulfate levels were similar in healthy 
controls and patients with CTS.
On the other hand, hypothyroidism has an im-
portant influence on central and peripheral nervous 
system.  The  patients  with  hypothyroidism  have 
complaint such as paresthesia, myalgia and muscle 
weakness.21 A number of studies reported that hy-
pothyroidism is associated with an increased risk of 
peripheral neuropathy22. CTS is the most common 
neuropathy  associated  with  hypothyroidism.22,23 
Hypothyroidism may cause to development of CTS 
leading alterations of fluid balance and peripheral 
tissue edema11. We did not find a trial evaluating se-
rum T3, T4 and TSH values in male patients with 
CTS in literature. However, there was not a differ-
ence for serum free T3, free T4 and TSH levels be-
tween two groups in our study.
However, our study has two limitations. The 
number  of  patients  that  included  the  study  was 
small and other limitation was wide age range of 
participants.
In conclusion, endocrine factors such as, free 
T3,  free  T4,  TSH,  free  testosterone,  dehydroepi-
androsterone sulfate and lipid levels like triglycer-
ide and total cholesterol, may not association with 
CTS in male patients. But further studies are needed 
to investigate association between endocrine factors 
and CTS levels in male and female patients.
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